11/14/2024
8:40 AM | JANUS HENDERSON GROUP PLC (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
9:27 AM | Capital International Investors (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
09/16/2024
7:00 PM | Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/16/2024
7:05 PM | Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:51 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
7:00 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/30/2024
4:03 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:00 AM | Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:50 PM | Sarepta Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2024
3:01 PM | Sarepta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/08/2024
7:00 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
7:00 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
7:00 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:35 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2024
3:16 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
3:19 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024
3:45 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
12:30 PM | BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
05/06/2024
7:00 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/06/2024
7:09 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
3:01 PM | Sarepta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:05 PM | Sarepta Therapeutics (Filer)
| Form DEF 14A | |
03/11/2024
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:00 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:00 PM | Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:02 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
6:03 PM | Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
4:38 PM | Sarepta Therapeutics (Subject)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:00 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:00 PM | Mayo Stephen (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump said you could learn something from this man (Ad) Early Warning: A Deep Crack Is Forming In The US Economy
Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.  Here’s everything you need to know. |
03/05/2024
7:00 PM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Mayo Stephen (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:34 PM | Mayo Stephen (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
6:55 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
6:42 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
3:47 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
12:34 PM | JANUS HENDERSON GROUP PLC (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
01/26/2024
4:26 PM | BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
01/08/2024
11:08 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free SRPT Stock Alerts